Trends in HR+ metastatic breast cancer survival before and after CDK4/6 inhibitor introduction in the United States: a SEER registry analysis of patients with HER2- and HER2+ metastatic breast cancer

Authors: Kwan, Marilyn L | Breast Cancer Research And Treatment | November 1, 2024 | PubMed abstract

Explore all publications

Back To Top